谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

PHASE 1 EVALUATION OF EVEROLIMUS (MTOR INHIBITOR) IN COMBINATION WITH VANDETANIB (MULTIKINASE INHIBITOR OF EGFR, VEGFR, AND RET) OR VEMURAFENIB (BRAF INHIBITOR) IN CHILDREN AND ADOLESCENTS WITH ADVANCED CANCERS

Vivek Subbiah,Michael Roxas,Winston Huh,Soumen Khatua,Cynthia Herzog,Najat Bitar Daw,Wafik Zaky,Michael Rytting, Daneshmand Maryam,Dennis Hughes, Jenny Berry, Estella Mote, Erika Ward,Funda Meric-Bernstam,Eugenie Kleinerman,Cindy Schwartz

PEDIATRIC BLOOD & CANCER（2015）

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要